Clinical Trial: Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584304) titled 'Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects' on May 07.

Brief Summary: An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508C and YHR2603 in healthy subjects

Study Start Date: July 10

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DRUG: YHP2508C

Test drug

DRUG: YHR2603

Comparator drug

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Yuhan Corporation

Disclaimer: Curated by HT Syndication....